CA2098298A1 - Formulations en aerosol - Google Patents
Formulations en aerosolInfo
- Publication number
- CA2098298A1 CA2098298A1 CA002098298A CA2098298A CA2098298A1 CA 2098298 A1 CA2098298 A1 CA 2098298A1 CA 002098298 A CA002098298 A CA 002098298A CA 2098298 A CA2098298 A CA 2098298A CA 2098298 A1 CA2098298 A1 CA 2098298A1
- Authority
- CA
- Canada
- Prior art keywords
- aerosol
- salt
- monohydrate
- ethanediamine
- carboxyethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63011490A | 1990-12-19 | 1990-12-19 | |
US07/630,114 | 1990-12-19 | ||
US64585091A | 1991-01-25 | 1991-01-25 | |
US07/645,850 | 1991-01-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2098298A1 true CA2098298A1 (fr) | 1992-06-20 |
Family
ID=27091083
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002098298A Abandoned CA2098298A1 (fr) | 1990-12-19 | 1991-03-28 | Formulations en aerosol |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0563048A1 (fr) |
JP (1) | JPH06503066A (fr) |
KR (1) | KR930703251A (fr) |
AU (1) | AU8642391A (fr) |
CA (1) | CA2098298A1 (fr) |
IE (1) | IE913482A1 (fr) |
PT (1) | PT99869A (fr) |
WO (1) | WO1992011236A1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010031244A1 (en) | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
DZ2947A1 (fr) * | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
IT1313553B1 (it) | 1999-07-23 | 2002-09-09 | Chiesi Farma Spa | Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. |
IT1317846B1 (it) | 2000-02-22 | 2003-07-15 | Chiesi Farma Spa | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. |
ME00220B (me) | 2000-05-22 | 2010-10-10 | Chiesi Farm Spa | Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom |
ES2222294T3 (es) | 2001-07-02 | 2005-02-01 | Chiesi Farmaceutici S.P.A. | Formulacion optimizada de tobramicina para administracion en forma de aerosol. |
EP1595531A1 (fr) | 2004-05-13 | 2005-11-16 | CHIESI FARMACEUTICI S.p.A. | Formulation d'une solution pharmaceutique stable pour aérosols doseurs sous pression |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4874792A (en) * | 1985-04-19 | 1989-10-17 | Smithkline Beckman Corporation | Thiophenyl Alkanoic acids useful as leukotriene antagonists |
-
1991
- 1991-03-28 CA CA002098298A patent/CA2098298A1/fr not_active Abandoned
- 1991-03-28 AU AU86423/91A patent/AU8642391A/en not_active Abandoned
- 1991-03-28 WO PCT/US1991/002177 patent/WO1992011236A1/fr not_active Application Discontinuation
- 1991-03-28 KR KR1019930701923A patent/KR930703251A/ko not_active Application Discontinuation
- 1991-03-28 EP EP91917474A patent/EP0563048A1/fr not_active Withdrawn
- 1991-03-28 JP JP3516136A patent/JPH06503066A/ja active Pending
- 1991-10-03 IE IE348291A patent/IE913482A1/en not_active Application Discontinuation
- 1991-12-19 PT PT99869A patent/PT99869A/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PT99869A (pt) | 1992-11-30 |
JPH06503066A (ja) | 1994-04-07 |
EP0563048A1 (fr) | 1993-10-06 |
KR930703251A (ko) | 1993-11-29 |
IE913482A1 (en) | 1992-07-01 |
AU8642391A (en) | 1992-07-22 |
WO1992011236A1 (fr) | 1992-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4005222A (en) | Mucolytic mercaptoacylamidobenzoic and benzenesulfonic acid compounds and process | |
US8765153B2 (en) | Levalbuterol salt | |
CA2098298A1 (fr) | Formulations en aerosol | |
EP0365119B1 (fr) | Composition pharmaceutique | |
US4132803A (en) | Mercaptoacylamidobenzoylglycine mucolytic process and compositions | |
KR101066801B1 (ko) | 항콜린제를 함유하는 hfa- 현탁 제형 | |
CA2183557A1 (fr) | Formule d'un aerosol medicamenteux contenant de la vitamine e | |
JPH03184967A (ja) | フロセミド塩、それらの製造法、薬剤としての使用及びそれらを含有する製薬組成物 | |
NZ232594A (en) | Aerosol formulation of nedocromil sodium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |